Stockreport

TD Cowen Initiates on MapLight (MPLT); Says It's Undervalued on Schizophrenia Alone [Yahoo! Finance]

MapLight Therapeutics, Inc.  (MPLT) 
PDF coverage on MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Buy rating. The analyst cited the company's pipeline of treatments targeting the central nervous system, or [Read more]